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Abstract
Estrogen receptors (ER), namely ERa and ERb, are hormone-activated transcription factors with an important role in
carcinogenesis. In the present study, we aimed at elucidating the implication of ERa in skin cancer, using chemically-
induced mouse skin tumours, as well as cell lines representing distinct stages of mouse skin oncogenesis. First, using
immunohistochemical staining we showed that ERa is markedly increased in aggressive mouse skin tumours in vivo as
compared to the papilloma tumours, whereas ERb levels are low and become even lower in the aggressive spindle tumours
of carcinogen-treated mice. Then, using the multistage mouse skin carcinogenesis model, we showed that ERa gradually
increases during promotion and progression stages of mouse skin carcinogenesis, peaking at the most aggressive stage,
whereas ERb levels only slightly change throughout skin carcinogenesis. Stable transfection of the aggressive, spindle CarB
cells with a dominant negative form of ERa (dnERa) resulted in reduced ERa levels and reduced binding to estrogen
responsive elements (ERE)-containing sequences. We characterized two highly conserved EREs on the mouse ERa promoter
through which dnERa decreased endogenous ERa levels. The dnERa-transfected CarB cells presented altered protein levels
of cytoskeletal and cell adhesion molecules, slower growth rate and impaired anchorage-independent growth in vitro,
whereas they gave smaller tumours with extended latency period of tumour onset in vivo. Our findings suggest an
implication of ERa in the aggressiveness of spindle mouse skin cancer cells, possibly through regulation of genes affecting
cell shape and adhesion, and they also provide hints for the effective targeting of spindle cancer cells by dnERa.
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Introduction
Skin cancer, both non-melanoma and melanoma, presents an
alertingly increasing incidence rate worldwide, followed by
substantial mordibity and raise of treatment cost. Risk factors for
non-melanoma skin cancer include excessive exposure to sunlight
or ultraviolet light, fair complexion and occupational exposure to
certain chemicals [1], as well as organ transplantation [2].
Although mortality due to primary non-melanoma skin cancer is
infrequent, prognosis is rather poor when metastasis occurs. The
five-year survival rates in case of metastatic non-melanoma skin
cancer are low, as a result of limited effectiveness of aggressive
treatment of metastatic carcinomas with radiation and/or
chemotherapy agents such as methotrexate, fluorouracil and
bleomycin [1].
An effective approach for investigating skin cancer is the mouse
skin carcinogenesis model developed previously, following a
protocol of chemical treatment of mouse epidermis with 7,12-
dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-
phorbol-13-acetate (TPA). This model consists of a series of cell
lines isolated from mouse tumours following a two-staged chemical
carcinogenesis protocol, which represent distinct stages of the full
range of mouse skin cancer development. It includes, but is not
limited to, an immortalized, non-tumourigenic keratinocyte cell
line (C5N), a benign papilloma cell line (P1), a squamous
carcinoma cell line (B9), which gives rise to well differentiated
tumours upon injection into nude mice, and finally highly
anaplastic, invasive spindle cell lines (A5, CarB) that exhibit
aggressive metastatic tumour growth in vivo. Although an artificial
system, it is ideal for analysis of the events that lead to the
transition through the stages of initiation to promotion and finally,
to progression of carcinogenesis [3].
Estrogen receptors (ERs) are transcription factors that regulate a
variety of genes both directly (ERE-containing genes, i.e. Estrogen
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Responsive Element-containing genes) and indirectly (non-ERE
containing genes, i.e. non-Estrogen Responsive Element-contain-
ing genes) and are implicated in oncogenic and apoptotic events in
a diverse range of estrogen-responsive target tissues [4,5]. There
are two types of estrogen receptors, ERa and ERb, which are
encoded by distinct genes, present differential tissue-specific
expression patterns [4] and form homo- as well as hetero-dimers,
when co-expressed in the same tissues. Since they share a 96%
amino acid identity in their DNA-binding domains (DBD), they
can bind to target sequences with similar affinities. The lower
(53%) homology in their ligand domains accounts for the
differences in their responses to various ligands (e.g. tamoxifen,
raloxifen and phytoestrogens), whereas their even less conserved
N-terminal transactivation domains enable interactions with
different proteins in the transcription complexes, thereby differ-
entiating their effects on target genes [6]. It has been suggested
that a ‘yin-yang’ relationship exists between ERa and ERb, since
ERa induces proliferation whereas ERb induces apoptosis in the
normal murine mammary cell line HC11 [7]. This antagonistic
relationship is further supported by the fact that ERa and ERb
exert opposing activities on activated protein-1 (AP-1) sites [8]. For
instance, the AP-1-driven promoter of cyclin D1 is activated by
ERa, but repressed by ERb [9]. This evidence has led to the
notion that it is the ERa/ERb ratio rather than the individual
receptor levels that is associated with carcinogenetic processes in
tissues where both ERa and ERb are expressed [10,11]. Indeed,
the ERa/ERb ratio has been found to be elevated in breast cancer
[12], as well as in uterine leiomyomas [13].
A recent report has highlighted a significant role of ERs in
nonmelanoma skin cancer, focusing particularly at the promotion
stage of chemically induced mouse skin oncogenesis. More
specifically, ovariectomized female mice, susceptible to papilloma
and squamous cell carcinoma (Car-S mice), presented an increase
in the papilloma incidence upon treatment with chemical
carcinogens in comparison with the intact control mice. Further-
more, the ERa/ERb ratio increased in papillomas from DMBA/
TPA-treated, ovariectomized Car-S mice compared to DMBA/
TPA-induced papillomas from, non-ovariectomized control ani-
mals, as a combined result of both elevated ERa levels and
reduced ERb levels. This increase subsequently led to the
upregulation of the typical ER target, cyclin D1, and of the
proliferation marker Ki67 in these animals [14].
Following this work and exploiting the well-established mouse
skin carcinogenesis model, we aimed to shed more light on the role
of ERs in the full spectrum of skin carcinogenesis, especially in the
progression stages, both in vitro and in vivo. We first estimated the
alteration in the expression of ERa and ERb in spindle skin
tumours from DMBA/TPA-treated mice compared to the
papilloma tumours. Then, we investigated ER levels and ER
binding activity in regards to skin cancer initiation, promotion and
progression stages (represented by C5N, P1, B9, A5 and CarB cell
lines) and we emphasized on the in vitro and in vivo effects of ERa-
specific targeting in the aggressive characteristics of CarB by
S554fs, a dominant negative mutant of ERa (dnERa). We also
clarified a new mechanism through which S554fs can exert its
inhibitory activities.
Results
Increased Levels of ERa and Decreased Levels of ERb are
Observed in Advanced Stages of Mouse Skin
Carcinogenesis
Initially, the status of ERa and ERb in early (papillomas) and
advanced (spindle tumours) stages of mouse skin carcinogenesis
in vivo was studied. Immunohistochemical expression of ERa was
assessed in chemically induced skin tumours from eight mice. In
the papillomas examined, only a faint nuclear staining for ERa
was observed, while spindle cell carcinomas exhibited a strong
nuclear staining for ERa (Fig. 1A). In contrast, ERb levels were
very low in papillomas and they were almost undetectable in
spindle cell carcinomas (Fig. 1B). To ensure that the antibodies
used on the paraffin sections are working properly, stable
transfected ERa-expressing HEK-293 cells and ERb-expressing
HEK-293 cells [15] were used as positive controls for staining with
anti-ERa and anti-ERb antibodies, correspondingly.
The ERa/ERb Ratio Increased During Promotion and
Progression Stages of Mouse Skin Carcinogenesis
The levels of both ERa and ERb in the multistage mouse skin
carcinogenesis cell lines C5N, P1, B9, A5 and CarB were then
estimated. We found ERa to be significantly elevated through
transition from the immortalized C5N cell line (initiation stage) to
the papilloma (promotion stage), squamous and spindle cell lines
(progression stages), overall presenting the highest levels of
expression in the CarB cell line. Notably, the most profound
increase in ERa levels was observed during transition from the
benign P1 cell line to the tumourigenic B9 cell line (Fig. 1C, 1D).
On the other hand, the protein levels of ERb in P1, B9 and A5 cell
lines only slightly changed in comparison with C5N, with the
lowest levels being those in the CarB cell line (Fig. 1D, 1E). The
corresponding ERa/ERb ratio gradually increased from the C5N
through the CarB cell line, being the highest in the most aggressive
CarB cells (Fig. 1F).
dnERa Reduces ERa Levels in the Spindle CarB Cell Line
Since CarB cells presented an over 3-fold elevation in ERa
levels compared to the immortalized C5N cell line (Figure 1E),
while at the same time having almost undetectable ERb levels,
they were deemed as ideal candidates for investigating the
effects of selective ERa inhibition in aggressive stages of skin
cancer. To this end, CarB cells were stably transfected with a
previously described [16] effective dnERa mutant, S554fs,
which carries a frameshift mutation at residue 554 of the
ligand binding domain (Fig. 2A). Three independently obtained,
stably transfected cell lines were produced, designated as C-ER
3, 4 and 7. Expression of the human dnERa in all three
transfectants in comparison with control parental CarB and
empty vector-transfected (CarB-V) cells was confirmed by
immunocytochemistry using the only commercially available
human-specific ERa antibody with documented lack of cross-
reactivity with mouse ERa (code LS-B2664, LifeSpan Biosci-
ences, WA, USA) (data not shown). In order to monitor
whether S554fs expression affects endogenous mouse ERa
levels, we performed Western blot analysis using an antibody
specific for both human and mouse ERa (code sc-2707, Santa
Cruz, CA, USA). The exogenous S554fs protein has the same
molecular weight as the wild type ERa protein and, thus, the
two ERa forms are indistinguishable by Western blot [17].
Therefore, mouse ERa levels were indirectly estimated by
comparing the total ERa protein levels in all three clones (i.e.,
endogenous ERa plus exogenous S554fs) with the endogenous
ERa levels of equally-loaded CarB and empty vector CarB-V
cell extracts. As shown in Figure 2B, introduction of the empty
vector in CarB cells does not alter endogenous ERa levels. Lack
of interference of exogenous S554fs protein with the endogenous
ERa levels would result in total ERa protein in all three clones,
detected by anti-ERa (sc-2707), being higher than the baseline,
endogenous ERa levels of CarB and CarB-V cells. Intriguingly,
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however, we found that the total levels of the protein product
were lower than the baseline ERa levels, indicating a negative
effect of dnERa protein on the endogenous ERa expression.
dnERa Reduces ERa Binding to Conserved EREs in the
Spindle CarB Cell Line
ERa binding to estrogen responsive elements (EREs) also
decreased upon introduction of the S554fs-containing plasmid in
Figure 1. Changes in ERa and ERb expression in skin carcinogenesis in vitro and in vivo. (A) Immunohistochemical expression of ERa is
enhanced in serial section of a spindle cell carcinoma in comparison with skin papilloma derived from chemical induction of carcinogenesis in
athymic mice. (B) Immunohistochemical staining of ERb is faint in spindle cell carcinomas in comparison with skin papillomas. Nuclear staining of the
positive control ERa-HEK293 cells and cytoplasmic staining of the ERb-HEK293 cells, which are used as positive controls validate the efficiency of anti-
ERa and anti-ERb, correspondingly, in this experimental setup. Symbols: Block arrows indicate positively stained nuclei, while arrowheads indicate
positively stained cytoplasm. The asterisks show macrophages. (C) Western blot with anti-ERa in total extracts of C5N, P1, B9, A5 and CarB cell lines
reveals that ERa is enhanced during transition from the immortalized C5N cell lines to the most aggressive CarB cell lines. (D) Western blot with anti-
ERb reveals slight changes of ERb during transition from the immortalized C5N cell lines to the most aggressive CarB cell lines. GAPDH protein
expression was used as a loading control. (E) Quantification of ERa and ERb levels in C5N, P1, B9, A5 and CarB cell lines (F) ERa/ERb ratio is gradually
increased during transition from the immortalized C5N through most aggressive CarB cell line.
doi:10.1371/journal.pone.0041957.g001
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CarB cells, as demonstrated by electrophoretic mobility shift assays
(EMSAs) performed in protein extracts from C-ER3, C-ER4 and
C-ER7 clones, using the well-characterized ERE sequence of the
vitellogenin promoter (vitERE), compared to Car-B and CarB-V
cells (Fig. 2C). Therefore, introduction of the dnERa mutant
causes decrease of ERa protein expression along with decrease of
ERa binding to ERE-containing targets in CarB cells. Since
S554fs is known to exert its inhibitory effects only by binding to
EREs as an inactive S554fs-ERa heterodimer [17], we examined
the possibility that this negative effect of S554fs in the wild type
ERa levels of C-ER 3, 4 and 7 clones is direct and could be
attributed to downregulation of the ERa gene itself via putative
ERE sequences on mouse ERa promoter. Using the ConTra
bioinformatics tool, we searched for conserved ERa binding sites
located in regions of mouse ERa promoter that show high
homology among various species, including Homo sapiens, Bos
taurus, Canis familiaris, Equus caballus, Pan troglodytes, Pongo pygmaeus,
Macaca mulatta and Rattus norvegicus. Indeed, the in silico analysis
revealed two highly conserved putative ERE elements both located
downstream of the transcription start site (TSS), within the intron
1–2 of the 59 UTR of the ERa gene (ID: EN-
SMUST00000105589) of Mus musculus (Fig. 2D). EREs span
1105 to 1123 and 1552 to 1570 bps downstream of the TSS,
whereas translation of the coding region starts within exon 2, 2230
bps downstream of the TSS (Fig. 2E). ERa can bind to these EREs
in vivo, as demonstrated by ChIP assays performed on CarB cells
using an anti-ERa antibody. ERa antibody immunoprecipitated
both EREs of the ERa promoter in CarB cells (Fig. 2F). In
contrast, no PCR signal was observed when the irrelevant
antibody b-actin was used for chromatin immunoprecipitation.
The sheared and cross-linked DNA that was produced prior to the
immunoprecipitation step (input) was used as a positive control
PCR template.
dnERa Alters the Morphology and the Oncogenic
Characteristics of CarB Cells in vitro
To further evaluate the effect of the introduction of the dnERa
mutant on the tumourigenic features of CarB cell line, we
monitored the morphology and growth rate of parental and
S554fs-transfected cells, as well as their ability to grow on soft agar.
Interestingly, we found that the S554fs-transfected CarB cells
tended to lose their spindle morphology. In contrast to the
characteristic spindle morphology of both parental and the CarB-
V cells, dnERa-transfected cells were enlarged and flattened and
became more roundish and more refractive to light (Fig. 3A). This
tendency of the transfected cells to acquire a rather epithelial-like
phenotype was accompanied by changes in the expression of
representative cytoskeletal molecules (increased vinculin and actin
levels) and extracellular matrix molecules (decreased integrin a1
levels), as shown in Fig. 3B. In addition, the S554fs-transfected
cells had a slower growth rate than the parental CarB and the
CarB-V cells (Fig 3C, 3D) and they finally reached confluence at
day 7, while vector-transfected cells reached confluence at day 3.
Soft agar assays revealed that the number of all three clones of the
dnERa-transfected cell lines was dramatically reduced compared
to parental or CarB-V cells (Fig. 3F), whereas their size was much
smaller (Fig. 3E), revealing impaired anchorage-independent
growth of dnERa transfectants. The immortalized keratinocyte
cell line C5N, which produced no colonies in soft agar, was used as
a negative control [18].
dnERa Suppresses Tumour Growth in vivo
We next assessed the in vivo effect of S554fs-ERa in the
metastatic stages of mouse skin carcinogenesis by subcutaneously
injecting dnERa-transfected cells into BALB/c SCID mice. Mice
injected with the empty vector-transfected CarB or the parental
CarB cells were used as controls. dnERa-CarB-injected mice
developed significantly smaller tumours (approximately 0.3 cm in
diameter) than the control CarB-V-injected mice (.1.5 cm in
diameter) (p,0.05, t-test) (Fig. 4A). There was a reduction in the
number of positive sites to the total number of injected sites of
dnERa-CarB-injected mice compared to the controls (Fig. 4B). In
addition, mice injected with dnERa-transfected cells present a
significant prolongation of the latency period of tumour onset in
comparison with the control parental or CarB-V-injected mice
(Fig. 4C). Histological examination of tumours demonstrated that
tumour cells from dnERa-CarB-injected mice had acquired an
epithelial-like appearance and did not invade the abdominal wall,
whereas tumour cells from control mice had a spindle,
fibroblastoid morphology and invaded the abdominal wall (data
not shown).
Discussion
Estrogen receptors respond to estrogen hormones, particularly
17 b-estradiol (referred as E2), and directly or indirectly affect
gene transcription via multiple ER-signaling pathways. In the
classical ligand- and ERE-dependent signaling pathway, E2
stimulation causes ER protein molecules to dimerize and bind to
specific EREs on target-gene promoters, where they recruit
coactivators/regulators and trigger transcription of both nuclear
and mitochondrial genes. ERE-containing genes may also
respond to ER in a ligand-independent manner, possibly through
stimulation of ER by intracellular kinases. Another ERE-
independent signalling pathway involves interaction of E2-ER
with other transcription factors, such as AP-1 and Sp1, bound to
non-ERE-containing target-genes. A third non-genomic, non-
transcriptional ER pathway involves a membrane-bound ER
which, upon E2 stimulation, activates various protein kinases,
such as MAPK, via cAMP [4,5].
Figure 2. Effect of the dominant negative S554fs-ERa on ERa levels of CarB cells. (A) Wild type and mutant form of ERa. The S554fs-ERa was
generated by random chemical mutagenesis of the ERa hormone binding domain (19). (B) Western blot analysis in equally-loaded protein extracts
from parental, control vector-transfected (CarB-V) and dnERa-transfected cells (C-ER3, C-ER4 and C-ER7) with an antibody that recognizes mouse and
human ERa (wild type and mutant). The levels of the total ERa protein (endogenous wild type plus exogenous mutant ERa) in all three clones
compared to the baseline ERa levels in CarB and CarB-V cells are reduced. (C) Electrophoretic mobility shift assay for ERa demonstrated lower binding
activity of ERa dimers to the estrogen response element of the vitellogenin promoter, vitERE, in the stable transfectant cell lines (lanes 2,3 and 4)
compared to the control CarB-V cells (lane1); N/S: non-specific binding. (D) The mouse ERa gene contains 2 putative estrogen responsive elements
(grey-highlighted), highly conserved among several animal species. (E) Schematic representation of the location of the putative EREs on the mouse
ERa gene. Two EREs (white blocks) are contained within intron 1–2 of ERa. The black shades indicate untranslated regions of exons 1 and 2, whereas
the grey shade indicates translated region of exon 2. The ATG codon is identified at +2230. (F) ChIP assay with DNA from CarB cells, using antibody
against ERa and PCR primer pairs that were specific for the ERE1- and ERE2-containing regions of ERa intron 1. Input was used as a positive control. A
reaction with no DNA (w/o DNA) and a reaction with b-actin-incubated chromatin for each of the ERE1 or ERE2 elements were used as negative
immunoprecipitation controls.
doi:10.1371/journal.pone.0041957.g002
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Figure 3. S554fs-ERa suppresses oncogenic properties of CarB-transfected cells and alters cytoskeletal and cell adhesion
molecules’ levels. (A) Phenotypic characteristics of dnERa-transfected clones (C-ER3, C-ER4) in comparison with untransfected and vector-
transfected CarB cells. The dnERa-transfected cells appear flattened and acquire a more epithelial morphology, whereas untransfected and vector-
transfected cells present a spindle morphology. (B) Growth rate assay reveals reduction in the growth rate of C-ER3 and C-ER4 cells in comparison
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Previous studies have clearly indicated a link between ERs and
skin cancer. For instance, ERb protects against UV radiation-
induced skin photocarcinogenesis probably via immunological
pathways, and specifically by inhibiting photoimmune suppres-
sion, a known risk factor for cancer skin development [19–21]. On
the other hand, an inbalanced ERa and ERb expression is
implicated in chemically induced skin carcinogenesis [14]. We
show here that ERa markedly increased in aggressive mouse skin
tumours in vivo as compared to the papilloma tumours, whereas
low papilloma ERb levels become even lower in the aggressive
spindle tumours. Moreover, using a mouse skin carcinogenesis
study model, we show that ERa protein levels gradually increase
during the promotion and progression stages of skin cancer,
peaking at the most aggressive stage, which is represented by the
CarB cell line. In contrast, ERb levels only slightly changed
throughout skin carcinogenesis, being lowest in CarB cells.
Consequently, the corresponding ERa/ERb ratio in these cell
lines generally increased in promotion and progression stages of
mouse skin carcinogenesis in comparison with the immortalized
C5N cell line, presenting the highest ratio in the most aggressive
CarB cells.
The in vitro and in vivo effects of reduction of the deregulated
ERa levels were next assessed by stably transfecting CarB spindle
cell line with S554fs, a well-studied dnERa mutant, which has
been characterized as a potent suppressor of ER-mediated
transcription in breast cancer cells [22]. It has been shown that
this dnERa mutant never binds to EREs as a homodimer [16] and
that it causes transcriptional silencing through heterodimerization
with wild type ERa monomers and antagonism with wild type
ERa homodimers for ERE binding. Interestingly, we observed
that introduction of this specific dominant negative (dn) mutant in
CarB cells additionally resulted in a reduction of the endogenous
ERa levels, along with the expected decrease of ERa-ERE
complexes. This is attributed to two highly conserved, functional
ERE sequences within intron 1–2 of the mouse ERa gene
promoter, through which S554fs is plausibly able to directly exert
its inhibitory effects. Therefore, activation of mouse ERa gene may
be repressed through competition of the inactive wtERa/S554fs-
ERa heterodimers with functional ERa homodimers for binding
to ERE sequences on the mouse ERa promoter itself. This leads to
inhibition of ERa synthesis and gradual reduction of the ERa
molecules in the cell’s ERa reservoir that are available for
composition of functional ERa homodimers, thus resulting in
further potentiation of the inhibitory transcriptional effects exerted
by the initially formed inactive wtERa/S554fs heterodimers.
Notably, a study has demonstrated that the human ERa promoter
contains a putative ERE which is autoregulated by ERa itself [23].
Taken together, these findings suggest that there might be a
possible conserved mechanism of autoregulation of ERa gene and
that powerful dnERa mutants such as S554fs could interfere with
this mechanism to mitigate the proliferative effects of deregulated
ERa expression. However, further studies are required to validate
this hypothesis.
Dominant negative forms of ER have shown antiproliferative
and tumour inhibitory effects upon introduction in several types of
cancer cells. For instance, adenovirus-mediated delivery of S554fs
mutant in the ER-positive MCF-7 breast cancer cell line effectively
suppresses estrogen-stimulated cell proliferation and hormonal
induction of endogenous genes [24]. Moreover, other dn ER
mutants effectively induce apoptosis in vitro and inhibit tumour
growth in vivo in breast cancer [25] as well as in leiomyomas [26].
In agreement with the above studies, we provide evidence on
interference of dnERa with the oncogenic and aggressive
characteristics of skin cancer cells, as well as with skin tumour
growth. The dnERa-transfected CarB cells exhibit suppression of
anchorage-independent growth, a key property of malignant cells
in vitro, whereas they generate fewer and smaller tumours with
extended latency period of tumour onset in severe combined
immunodeficient (SCID) mice. Overall, the above data provide
optimistic insights on the use of dn forms of ER in the targeting of
ER-mediated oncogenic activities in several cancer types.
Moreover, our study provides evidence of correlation of an
imbalanced ERa/ERb ratio with the expression of molecules that
affect shape and adhesion of skin cancer cells, since introduction of
dnERa in the aggressive metastatic CarB cell line increases
vinculin and actin protein levels and decreases integrin a1 protein
levels. The effect of the dnERa mutant on cell shape and
expression of cytoskeletal proteins in CarB cells presents similar-
ities with that of the selective ER modulator, tamoxifen, in MCF-7
cells, which has been shown to increase vinculin and actin levels,
promote rearrangement of cytoskeletal structures and result in cells
with a more roundish and flattened morphology [27]. Alterations
in molecules that influence cell shape and adhesion have been
correlated with conversion of mouse skin carcinomas of epithelial
morphology to spindle cell carcinomas of higher metastatic
potential [28]. Therefore, it is likely that one way of suppression
of the aggressiveness of CarB cell line by dnERa may involve cell
structural alterations which ultimately result to reversion of the
spindle phenotype.
Furthermore, integrins enable cell adhesion and transduce
intracellular signals that promote cell survival and migration
[29,30] and they have recently been linked to both skin cell
proliferation and ER expression. In particular, studies in integrin
a1-null mice revealed that integrin a1 induces skin cell prolifer-
ation [31]. On the other hand, Lindberg et al reported that integrin
a1 levels are affected by ERs in human breast cancer cells, possibly
via a putative ERE within a region extending 10 kbps upstream of
the transcription start site (TSS) of the human integrin a1 gene
[32]. In concordance with these findings, we have also observed
alterations in the integrin a1 levels upon introduction of dnERa in
CarB cells. Moreover, we have found a putative ERE positioned
24297 to24279 bps upstream of the TSS of the integrin a1 gene,
which is highly conserved among 11 mammalian species,
including humans (unpublished data). In this context, an intriguing
question that should be investigated in future studies is whether the
observed reduction of integrin a1 in dnERa-transfected CarB cells
is mediated by ERE-dependent pathways and whether it is linked
with control vector-transfected CarB cells. (C) Cell growing of vector-transfected CarB, C-ER3 and C-ER4 cells is expressed in OD values at 595 nm, in
24 h, 48 h and 72 h. All the results are plotted as mean 6 standard deviations from three independent experiments. (D) Representative illustrations
of anchorage-independent growth of CarB-V, C-ER3 and C-ER4 cells. (E) Western blot analysis for determination of levels of actin, vinculin and integrin
a1 proteins in parental, CarB-V cells and S554fs-transfected CarB cells. Actin and vinculin protein expression increased, whereas integrin a1 expression
decreased in all three transfected clones compared to the Car-B and CarB-V cells. GAPDH protein expression was used as a loading control. (F)
Summary graph (means6SEM from triplicates) for soft agar cloning efficiency of parental control, vector-transfected and dnERa transfected spindle
cell lines. Colonies were scored after 3 to 4 weeks. CarB-V is compared against CarB, C-ER3, C-ER4 and C-ER7 using t-test, and results are flagged with
no asterisk when P-value is more than 0.05, with a single asterisk when the P-value is less than 0.05, with two asterisks when the P-value is less than
0.01, and three asterisks when the P-value is less than 0.001.
doi:10.1371/journal.pone.0041957.g003
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to the impaired anchorage-independent growth and/or the
reduced proliferation rate that lead to the mitigation of the
oncogenic features of malignant CarB cells.
Overall, our data strongly suggest that ERa-specific targeting
can effectively reverse the aggressive malignant mouse skin
phenotypes. This reversion is reflected in the loss of spindle
morphology, which could be a result of respective changes in the
levels of critical cytoskeletal and cell adhesion molecules. Still, the
identification of putative, direct or indirect ER gene targets in skin
carcinogenesis and the documentation of an axis between ER and
cell structure/adhesion molecules that may underlie ER oncogenic
effects are subjects for fruitful research. Oncoming cutting-edge,
high-throughput analyses of dnERa-suppressed cells versus
parental cancer cells will further assist identification of the direct
Figure 4. In vivo effect of S554fs-ERa on the biologically aggressive behaviour of mouse spindle cells. (A) Injection of C-ER3 and C-ER4
cells in BalB/c SCID mice resulted to a reduction in the number of the positive sites compared to the control CarB-V-injected mice, as well as to
smaller tumours. Tumour sites are circled in black. (B) Tumorigenicity (positive sites/mouse) of control and dnERa transfected CarB cell lines. (C)
Latency period (weeks) of tumours in dnERa-CarB injected mice as compared to parental and mock-transfected cells. Corresponding summary graphs
(means6SEM from 7 to 8 mice) derived by comparison of mice injected with CarB-V against CarB, C-ER3, C-ER4 and C-ER7 using t-test. Results are
flagged with no asterisk when P-value is more than 0.05, with a single asterisk when the P-value is less than 0.05, with two asterisks when the P-value
is less than 0.01, and three asterisks when the P-value is less than 0.001.
doi:10.1371/journal.pone.0041957.g004
Involvement of ERa in Mouse Skin Carcinogenesis
PLoS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e41957
and indirect targets of ERa that mediate its oncogenic effects in
this cancer type.
With respect to skin cancer therapy, thorough understanding of
the role of ERs and optimization of ER-targeting could ultimately
enable improvement of current treatment regimes and alleviate
obstacles in the management of skin cancer risk. In particular, the
failure of patients with aggressive skin cancer to respond to the
conventional systemic chemotherapy [1], as well as the poor
tolerance of special groups of skin cancer-prone patients (e.g.
immunosuppressed transplant recipients) in chemoprophylaxis
[33] necessitate the development of new, alternative strategies
for effective and safe molecular therapeutics against this cancer
type. An example of such an approach suggested recently is tissue-
specific intervention in ER-mediated oncogenesis pathways [34].
The consistent tumour growth-suppressive effects of dn forms of
ERa in ERa-positive epithelial tumours [25,26 and this study],
encourage experimental attempts towards the introduction of
dnERa in tissue-specific targeting in the setting of the skin cancer
treatment.
Materials and Methods
Ethics Statement
Experiments with mice were performed in the authorized
animal house of the National Hellenic Research Foundation.
Experiments complied with the Protocol on the Protection and
Welfare of Animals, as obliged by the rules of the National
Hellenic Research Foundation, the regulations of the National
Bioethics Committee and the article 3 of the presidential decree
160/1991 (in line with 86/609/EEC directive) regarding the
protection of experimental animals. Please note that all experi-
ments with mice were performed according to the local,
institutional and EU guidelines for the protection and welfare of
animals (NHRF Bioethics Committee). These experiments are
always performed in the legal and authorized in-house animal
facility of our institution.
Two-stage Chemical Carcinogenesis Protocol
The backs of 10-week old mice were shaved and treated with a
single application of DMBA (25 mg in 200 mL acetone) followed by
a biweekly application of TPA (200 mL of 1024 M solution in
acetone) for 20 weeks. Mice were visually examined weekly and
were sacrificed if moribund, if any individual tumour reached a
diameter of 1 cm, or at the termination of the experiments.
Tumours from sacrificed animals were snap-frozen in liquid
nitrogen, fixed in formalin, embedded in paraffin and were
sectioned for immunohistochemical staining.
Immunohistochemical Staining
Immunohistochemistry was performed as described earlier [18].
The sections were stained with ERa (sc-7207; Santa Cruz, Santa
Cruz, CA, USA) and ERb (sc-8974; Santa Cruz, Santa Cruz, CA,
USA) primary antibodies in a 1:200 and 1:100 dilution,
respectively.
Cells and Culture Conditions
Cell lines were produced and kindly provided by Dr. A.
Balmain (reviewed in [3]). All cell lines were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and penicillin/streptomycin. Cells
were incubated in a humidified atmosphere with 5% CO2 at 37uC.
The ERa-GEK and ERb-GEK stably transfected clones were a
kind gift of Dr. M. Alexis [15].
Preparation of Total Cell Lysates
Cells were washed twice in ice-cold phosphate-buffered saline
and lysed in lysis buffer (20 mM Tris pH 7.6, 0.5% Triton X-100,
25 mM NaCl, 3 mM EDTA, 3 mM EGTA, 10 mg/mL pefabloc,
2 mM sodium orthovanadate, 10 mg/mL aprotinin, 10 mg/mL
leupeptin and 1 mM dithiotreitol). Cells were incubated on ice for
30 min and centrifuged at 12,000 rpm, 4uC for 10 min. Protein
estimations were performed by the Bradford method [35].
Western Blot Analysis
Total cell lysates (40 mg) were electrophoresed on a 10% SDS-
polyacrylamide gel under reducing conditions. Proteins were
transferred to nitrocellulose membrane and blocked for 1 h at
room temperature in 5% non-fat dry milk with TBS-0.1% Tween
20. The blots were subsequently incubated overnight at 4uC with
the corresponding primary antibodies. Primary antibodies used
were purchased from Santa Cruz (anti-ERa, code sc-7207; anti-
ERb, code sc-8974; anti-actin, code sc-1616; anti-integrin a1,
code sc-10728; anti-vinculin, sc-25336). Anti-GAPDH (sc-20357,
Santa Cruz, Santa Cruz, CA, USA) was used as a loading control.
Primary antibodies were diluted 1:1000 to 1:2000 in 5% non-fat
dry milk with TBS-0.1%-Tween 20. After three 10-min washes in
TBS-0.1% Tween 20, the blots were incubated with the
corresponding horseradish peroxidase-conjugated secondary anti-
bodies (1:5000 dilution in 1% non-fat dry milk with TBS-1%
Tween 20) for 2 h at room temperature. Detection of protein
levels was carried out using an enhanced chemiluminescence
system (Thermo Scientific-Pierce, IL, USA). Protein levels were
normalized to GAPDH and quantification was performed as
previously described [36].
Electrophoretic Mobility Shift Assay
Annealed oligonucleotides for the vitellogenin Estrogen Re-
sponsive Element (59-AGC TTC AAA GTC AGG TCA CAG
TGA CCT GAT CAA AGA-39) and (59-AGC TTC TTT GAT
CAG GTC ACT GTG ACC TGA CTT TGA-39) [37] were end-
labelled with c32P-ATP using T4 polynucleotide kinase and the
reaction products were purified on a 8% polyacrylamide gel. DNA
binding reactions were carried out by mixing 2,000 cpm of
[c-32P]ATP-labeled oligonucleotide with 20 mg of total cell protein
in binding buffer [50 mM HEPES (pH 8.0), 500 mM NaCl,
0.5 M PMSF, 0.5 mg/mL BSA, 20% glycerol, 1 mM EDTA) plus
1 mM DTT and 150 mg/mL poly(dI-dC) (Sigma-Aldrich,
St Louis, MO, USA). The reaction mixture was left at room
temperature for 30 min and the samples were subsequently
subjected to electrophoresis on a 6% polyacrylamide gel at
150 V for 90 min, dried and visualized by autoradiography.
Chip Assay
Chromatin immunoprecipitation assays in CarB cells were
performed as previously described [36]. Chromatin was precipi-
tated either with ERa antibody (kindly provided by Dr. M. Alexis)
[15] or b-actin antibody (Santa Cruz, CA, USA). The pelleted
DNA was resuspended in 10 mL and amplified by PCR. The
following PCR primers were used: for ERE1, forward: CGCCA-
GAGCTTTAGTCAAGG, reverse: CACACTTGGGTGTCCC-
TACC; for ERE2 forward: ACACACCCCATCCTATTTGC,
reverse: GCCAAGCTCCAATCTGTCTC.
Plasmids and Transfections
CarB cells were transfected with a mixture of a plasmid
containing the S554fs dominant negative ERa frameshift mutant
[16] (kindly provided by Dr. B. Katzenellenbogen) and a
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pCMVneo plasmid (which confers resistance to geneticin) in a 10:1
ratio, using the calcium phosphate method [38]. Control CarB-V
cells were transfected by pCMVneo alone. Following 18 h of
incubation, the cells were washed twice in PBS and incubated for
24 h in fresh DMEM medium supplemented with 10% FBS.
Twenty four hours later the cells were diluted and incubated in
DMEM supplemented with 10% FBS under selective conditions
(1000 mg/mL geneticin) (Sigma-Aldrich, St Louis, MO, USA) for
2 weeks. Individual geneticin-resistant colonies were isolated with
cylinder trypsinization and were grown in DMEM supplemented
with 10% FBS.
Growth Rate Assay
46104 cells were plated in 6-well culture dishes and allowed to
grow in DMEM supplemented with 10% FBS. The growth rates
of parental and transfected cell lines were compared 24, 48 and
72 h after plating of cells. The cells were methanol-fixed and
stained with 0.5% crystal violet solution. Excess dye was removed
under running tap water and the dishes were air dried and
destained with 33% acetic acid. The absorbance was measured at
595 nm. The assay was performed in triplicate.
Anchorage-independent Growth
56103 cells were plated onto 3 mL DMEM containing 10%
FBS and 0.3% agar, over a solidified cushion of 2 mL DMEM
containing 10% FBS and 0.6% agar. Cells were allowed to grow
for two weeks and 0.5 mL of fresh DMEM supplemented with
10% FBS was added into the wells every 2 days. Individual
macroscopic colonies were finally counted [39]. Colonies were
scored after 3 to 4 weeks and each value was calculated as an
averaged score of three independent experiments.
In vivo Tumourigenicity Studies
Parental CarB, control vector-transfected CarB-V and S554fs
stable transfectant cells, were harvested, washed and resuspended
in PBS. Approximately 106 cells were injected subcutaneously at
two sites in the abdominal region of female 6-week-old Balb/c
severe combined immunodeficient (SCID) mice (The Jackson
Laboratory, Bar Harbor, ME). This strain is routinely used in
oncogenicity protocols to avoid bias due to immunological
responses of mice to injected cells. Tumour growth was monitored
2 times weekly and animals were killed when tumours reached a
diameter or approximately 1.5 cm or at the end of the observation
period.
Bioinformatic Analysis
GeneCards [40] was used for the identification of the HGNC
gene symbols of the genes of interest. ConTra [41], a promoter
alignment analysis web tool for identification of EREs across
species was used, as follows. For each gene symbol, the Ensembl
[42] transcript with most downstream Transcription Start Site
(TSS) was selected. The sequences were compared against
V$ER_Q6 TRANSFAC position weight matrix of ERa target
motifs using MATCH algorithm [43] with a core cutoff of 0.95
and a similarity matrix cut-off of 0.85. ConTra output genomic
sequence alignments where potential ER binding sites appeared in
colour. Conserved potential ER binding sites were identified,
through visual inspection.
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